Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 20, 2020 9:15 AM 1 min read

Nike Picks Up Orders In Times Of Distress, Analyst Says In Upgrade

by Lizzy Balboa Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

Nike Inc (NYSE:NKE), like many of its major distributors, has temporarily shuttered stores to help fight the spread of the coronavirus. Distributors that remain open continue to lose foot traffic as customers practice precautionary isolation.

The resulting sales cut doesn’t look great on the surface, but one analyst isn’t too concerned.

The Rating

BofA Securities analyst Robert Ohmes upgraded Nike to Buy but cut their price target from $110 to $85.

The Thesis

BofA halved its 2020 bottom-line estimates and adjusted its sales forecasts to reflect a 46% drop in the May quarter. The latter anticipates a $2 billion annual decline in North America and $1 billion fall in China, Europe and the Middle East.

Still, the analysts consider Nike relatively well positioned.

“We believe NKE remains the key brand that wholesale customers shift orders to in times of distress and should also benefit from its superior sourcing capabilities, with a vertically integrated supply chain and more consolidated supplier base,” Ohmes wrote in a note.

Nike shares have suffered a 30% pullback since the coronavirus outbreak began. BofA upgraded the stock as it trades at levels not seen since mid-2018.

“We believe current global athletic momentum favors NKE in both footwear (led by the Air Force 1 and Air Jordan 1 styles) and apparel (led by Sportswear) and believe an overall challenging environment could enhance NKE’s global market share momentum,” the analysts wrote.

NKE Price Action

At time of publication, Nike shares traded up 2.4% around $72.01.

Related Links:

Here's How Long It Took Nike To Reach A $100B Market Cap

Here's Who Could Take A Massive Hit If The 2020 Olympics Were Canceled

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorUpgradesPrice TargetAnalyst RatingsBank of AmericaRobert Ohmes
NKE Logo
NKENike Inc
$56.99-0.04%
Overview
NKE Logo
NKENike Inc
$56.99-0.04%
Overview
Comments
Loading...